133 related articles for article (PubMed ID: 11518790)
21. Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells.
Muta K; Krantz SB; Bondurant MC; Wickrema A
J Clin Invest; 1994 Jul; 94(1):34-43. PubMed ID: 7518834
[TBL] [Abstract][Full Text] [Related]
22. Treatment of postrenal transplant erythrocytosis. Long-term efficacy and safety of angiotensin-converting enzyme inhibitors.
MacGregor MS; Rowe PA; Watson MA; Rodger RS; Junor BJ; Briggs JD
Nephron; 1996; 74(3):517-21. PubMed ID: 8938674
[TBL] [Abstract][Full Text] [Related]
23. Posttransplant erythrocytosis: a model for the investigation of the pharmacological control of renal erythropoietin production?
Gleiter CH
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):489-92. PubMed ID: 8937931
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor I plays a role in regulating erythropoiesis in patients with end-stage renal disease and erythrocytosis.
Shih LY; Huang JY; Lee CT
J Am Soc Nephrol; 1999 Feb; 10(2):315-22. PubMed ID: 10215331
[TBL] [Abstract][Full Text] [Related]
25. Effect of enalapril on exaggerated erythropoietin response to phlebotomy in erythrocytosic renal transplant patients.
Usalan C; Erdem Y; Cağlar M; Altun B; Arici M; Bakkaloğlu M; Yasavul U; Turgan C; Cağlar S
Nephrol Dial Transplant; 1998 Nov; 13(11):2884-9. PubMed ID: 9829495
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of contributing factors of post transplant erythrocytosis in renal transplant patients.
Ahmed S; Ahmed E; Naqvi R; Qureshi S
J Pak Med Assoc; 2012 Dec; 62(12):1326-9. PubMed ID: 23866484
[TBL] [Abstract][Full Text] [Related]
27. Posttransplant erythrocytosis: an enigma revisited.
Gaston RS; Julian BA; Curtis JJ
Am J Kidney Dis; 1994 Jul; 24(1):1-11. PubMed ID: 8023814
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin.
Muta K; Krantz SB
J Cell Physiol; 1993 Aug; 156(2):264-71. PubMed ID: 7688370
[TBL] [Abstract][Full Text] [Related]
29. Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis.
Julian BA; Gaston RS; Barker CV; Krystal G; Diethelm AG; Curtis JJ
Kidney Int; 1994 Nov; 46(5):1397-403. PubMed ID: 7853800
[TBL] [Abstract][Full Text] [Related]
30. Losartan versus ramipril in the treatment of postrenal transplant erythrocytosis.
Hortal L; Fernández A; Vega N; Rodríguez JC; Losada A; Lorenzo M; Plaza C; Palop L
Transplant Proc; 1998 Aug; 30(5):2127-8. PubMed ID: 9723415
[No Abstract] [Full Text] [Related]
31. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
[TBL] [Abstract][Full Text] [Related]
32. Does Renal Tubular Injury-Induced Local Tissue Hypoxia Involve Post-Transplantation Erythrocytosis?
Unal A; Ata S; Karakurkcu C; Ciraci MZ; Kocyigit I; Sipahioglu MH; B Tokgoz ; Oymak O
Transplant Proc; 2017 Oct; 49(8):1930-1934. PubMed ID: 28923650
[TBL] [Abstract][Full Text] [Related]
33. Posttransplant erythrocytosis.
Vlahakos DV; Marathias KP; Agroyannis B; Madias NE
Kidney Int; 2003 Apr; 63(4):1187-94. PubMed ID: 12631334
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of enalapril after ineffective theophylline treatment on erythrocytosis after renal transplantation.
Yagisawa T; Toma H; Yaguchi H; Tomaru M; Iijima Y; Suzuki H; Nakada T
Int Urol Nephrol; 1997; 29(3):363-7. PubMed ID: 9285312
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-converting enzyme inhibitors after renal transplantation.
Bravo P; Felgueiras J; Santos C; Oliveira C; Ponce P
Transplant Proc; 2008 Apr; 40(3):740-2. PubMed ID: 18455003
[TBL] [Abstract][Full Text] [Related]
36. Posttransplant erythrocytosis: a possible nonerythropoietin-mediated mechanism.
Morrone LF; Schena A; Di Paolo S; Stallone G; Schena FP
Transplant Proc; 1997; 29(1-2):223. PubMed ID: 9122971
[No Abstract] [Full Text] [Related]
37. Insulin and insulin-like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptors.
Miyagawa S; Kobayashi M; Konishi N; Sato T; Ueda K
Br J Haematol; 2000 Jun; 109(3):555-62. PubMed ID: 10886204
[TBL] [Abstract][Full Text] [Related]
38. A randomized placebo-controlled study of enalapril in the treatment of erythrocytosis after renal transplantation.
Beckingham IJ; Woodrow G; Hinwood M; Rigg KM; Morgan AG; Burden RP; Broughton-Pipkin F
Nephrol Dial Transplant; 1995 Dec; 10(12):2316-20. PubMed ID: 8808232
[TBL] [Abstract][Full Text] [Related]
39. The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under serum-free conditions--comparison to other cytokines and growth factors.
Ratajczak J; Zhang Q; Pertusini E; Wojczyk BS; Wasik MA; Ratajczak MZ
Leukemia; 1998 Mar; 12(3):371-81. PubMed ID: 9529132
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin-converting enzyme inhibitors for secondary erythrocytosis.
Fakhouri F; Grünfeld JP; Hermine O; Delarue R
Ann Intern Med; 2004 Mar; 140(6):492-3. PubMed ID: 15023727
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
